Minerva Neurosciences Corp (NERV) - Biznesning o‘zini qoplash muddati
Minerva Neurosciences (NERV) aksiyalarining narx dinamikasi joriy -0.40 ko'rsatkichini aks ettiradi. Minerva Neurosciences roluperidone litsenziyasini tayyorlash uchun global laboratoriyalar bilan hamkorlikdan foydalangan holda shizofreniya uchun davolash usullarini ishlab chiqmoqda. Kompaniya strategiyasi samarali terapiyalarning yetishmasligini bartaraf etish orqali bemorlarning ijtimoiy moslashuviga e'tibor qaratadi. Biroq, FDA bilan bog'liq tartibga soluvchi qiyinchiliklar uning bozordagi mavqeini zaiflashtirdi va biznesni himoya qilishni yangi, qimmat tadqiqotlarga bog'liq qoldirdi.
Minerva Neurosciences Corp (NERV) kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Minerva Neurosciences|NERV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Minerva|NERV - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Minerva Neurosciences, Inc.|NERV - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Minerva Neurosciences|Shoshilinch likvidlik koeffitsiyenti minervaneurosciences.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
NERV - Sof foyda|Kutilayotgan sof foyda Minerva Neurosciences|NERV - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Minerva Neurosciences Inc|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Minerva Neurosciences, Inc.|NERV - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Minerva Neurosciences|NERV - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi minervaneurosciences.com|NERV - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Minerva Neurosciences
Kompaniyaning jamlanma tahlili:NERV, minervaneurosciences.com
Aktiv qiymatini ob'ektiv baholash uchun menejer bozor kapitalizatsiyasining yillik sof foydaga nisbatini tahlil qilishi kerak, bu esa investitsiyalarning qoplanish muddatini belgilaydi. Minerva Neurosciences (NERV) kompaniyasining P/E grafigini o'rganishda, investor kompaniyaning savdo hajmi yo'qligi sababli buzilishlarni kuzatadi, chunki shizofreniya dori vositasini bozorga chiqarish bilan bog'liq xarajatlar salbiy natija keltirib, klassik koeffitsientni vaqtincha ahamiyatsiz qilib qo'yadi.
Raqobatdosh kompaniyalar
Narx-foyda koeffitsiyenti biogen.com (BIIB)|P/E multiplikatori NBIX|Biznesning o‘zini qoplash muddati Regencell Bioscience Ltd|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACAD: Narx-foyda multiplikatori|Xenon Pharmaceuticals - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati vikingtherapeutics.com|Supernus (SUPN) - Narxning foydaga nisbati|Catalyst Pharma - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti DNLI|Narxning foydaga nisbati HRMY|P/E multiplikatori BHVN|P/E multiplikatori amylyx.com (AMLX)|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|AVXL - Narxning foydaga nisbati|CBLL (CeriBell EEG) - Narx-foyda multiplikatori|PRTA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Alector (ALEC)|Narx-foyda koeffitsiyenti ANNX|P/E multiplikatori Omeros Corp.|Narxning foydaga nisbati Neurogene Corp (NGNE)|ACIU (AC Immune Inc) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Voyager Therapeutics VYGR|neumoratx.com (NMRA) - Kapitalizatsiyaning foydaga nisbati|SCLX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tevogen Bio Holdings Inc. TVGN|ACOG: P/E multiplikatori|Narx-foyda koeffitsiyenti Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - P/E multiplikatori|cassavasciences.com (SAVA) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ASRT|COYA - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Vistagen VTGN|OVID: Narx-foyda multiplikatori|Acumen Pharmaceuticals - P/E multiplikatori|cervomed.com (CRVO) - Narx-foyda koeffitsiyenti|ATHE: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Clene (CLNN)|Narxning foydaga nisbati PepGen Inc|Jupiter Neurosciences, Inc. (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics (RLMD)|annovisbio.com - Narx-foyda multiplikatori|P/E multiplikatori GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Kapitalizatsiyaning foydaga nisbati|KLTO - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati NRSN (NeuroSense Therapeutics)|RVPH (Reviva Pharmaceuticals) - Narx-foyda koeffitsiyenti|MTVA (MetaVia) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis|Narx-foyda multiplikatori HSDT (Helius Medical Technologies Inc.)|P/E multiplikatori PASG|NEUP - Kapitalizatsiyaning foydaga nisbati|Athira Pharma, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori addextherapeutics.com ADXN|ALZN - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CYCN (Cyclerion Therapeutics)|protagenic.com (PTIX) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pasithea Therapeutics Corp. (KTTA)|Narxning foydaga nisbati Cortigent Inc|Narx-foyda koeffitsiyenti avenuetx.com (ATXI)|P/E multiplikatori BCLI|Biznesning o‘zini qoplash muddati Cara Therapeutics Inc.|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM: Narx-foyda multiplikatori|Intra-Cellular - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGen Biotech Inc - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti NRBO|Narxning foydaga nisbati SAGE|P/E multiplikatori SNPX|P/E multiplikatori trevena.com (TRVN)|Vigil Neuroscience, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati WENA|CERE - Narxning foydaga nisbati
